Cargando…

PB1814: THERAPEUTIC POTENTIAL AND STRATEGIES OF PIM447, A PAN-PIM INHIBITOR, TARGETING REFRACTORY MYELOID LEUKEMIA WITH KIT-DRIVEN T(8/21)

Detalles Bibliográficos
Autores principales: Tseng, Chi-Yang, Yu, Ya-Chu, Kuo, Chia-Hung, Su, Kuan-Wei, Ho, Kam Hoi, Ou, Da-Liang, Hou, Hsin-An, Lin, Liang-In
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429858/
http://dx.doi.org/10.1097/01.HS9.0000974104.43771.64
_version_ 1785090816428998656
author Tseng, Chi-Yang
Yu, Ya-Chu
Kuo, Chia-Hung
Su, Kuan-Wei
Ho, Kam Hoi
Ou, Da-Liang
Hou, Hsin-An
Lin, Liang-In
author_facet Tseng, Chi-Yang
Yu, Ya-Chu
Kuo, Chia-Hung
Su, Kuan-Wei
Ho, Kam Hoi
Ou, Da-Liang
Hou, Hsin-An
Lin, Liang-In
author_sort Tseng, Chi-Yang
collection PubMed
description
format Online
Article
Text
id pubmed-10429858
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104298582023-08-17 PB1814: THERAPEUTIC POTENTIAL AND STRATEGIES OF PIM447, A PAN-PIM INHIBITOR, TARGETING REFRACTORY MYELOID LEUKEMIA WITH KIT-DRIVEN T(8/21) Tseng, Chi-Yang Yu, Ya-Chu Kuo, Chia-Hung Su, Kuan-Wei Ho, Kam Hoi Ou, Da-Liang Hou, Hsin-An Lin, Liang-In Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429858/ http://dx.doi.org/10.1097/01.HS9.0000974104.43771.64 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Tseng, Chi-Yang
Yu, Ya-Chu
Kuo, Chia-Hung
Su, Kuan-Wei
Ho, Kam Hoi
Ou, Da-Liang
Hou, Hsin-An
Lin, Liang-In
PB1814: THERAPEUTIC POTENTIAL AND STRATEGIES OF PIM447, A PAN-PIM INHIBITOR, TARGETING REFRACTORY MYELOID LEUKEMIA WITH KIT-DRIVEN T(8/21)
title PB1814: THERAPEUTIC POTENTIAL AND STRATEGIES OF PIM447, A PAN-PIM INHIBITOR, TARGETING REFRACTORY MYELOID LEUKEMIA WITH KIT-DRIVEN T(8/21)
title_full PB1814: THERAPEUTIC POTENTIAL AND STRATEGIES OF PIM447, A PAN-PIM INHIBITOR, TARGETING REFRACTORY MYELOID LEUKEMIA WITH KIT-DRIVEN T(8/21)
title_fullStr PB1814: THERAPEUTIC POTENTIAL AND STRATEGIES OF PIM447, A PAN-PIM INHIBITOR, TARGETING REFRACTORY MYELOID LEUKEMIA WITH KIT-DRIVEN T(8/21)
title_full_unstemmed PB1814: THERAPEUTIC POTENTIAL AND STRATEGIES OF PIM447, A PAN-PIM INHIBITOR, TARGETING REFRACTORY MYELOID LEUKEMIA WITH KIT-DRIVEN T(8/21)
title_short PB1814: THERAPEUTIC POTENTIAL AND STRATEGIES OF PIM447, A PAN-PIM INHIBITOR, TARGETING REFRACTORY MYELOID LEUKEMIA WITH KIT-DRIVEN T(8/21)
title_sort pb1814: therapeutic potential and strategies of pim447, a pan-pim inhibitor, targeting refractory myeloid leukemia with kit-driven t(8/21)
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429858/
http://dx.doi.org/10.1097/01.HS9.0000974104.43771.64
work_keys_str_mv AT tsengchiyang pb1814therapeuticpotentialandstrategiesofpim447apanpiminhibitortargetingrefractorymyeloidleukemiawithkitdrivent821
AT yuyachu pb1814therapeuticpotentialandstrategiesofpim447apanpiminhibitortargetingrefractorymyeloidleukemiawithkitdrivent821
AT kuochiahung pb1814therapeuticpotentialandstrategiesofpim447apanpiminhibitortargetingrefractorymyeloidleukemiawithkitdrivent821
AT sukuanwei pb1814therapeuticpotentialandstrategiesofpim447apanpiminhibitortargetingrefractorymyeloidleukemiawithkitdrivent821
AT hokamhoi pb1814therapeuticpotentialandstrategiesofpim447apanpiminhibitortargetingrefractorymyeloidleukemiawithkitdrivent821
AT oudaliang pb1814therapeuticpotentialandstrategiesofpim447apanpiminhibitortargetingrefractorymyeloidleukemiawithkitdrivent821
AT houhsinan pb1814therapeuticpotentialandstrategiesofpim447apanpiminhibitortargetingrefractorymyeloidleukemiawithkitdrivent821
AT linliangin pb1814therapeuticpotentialandstrategiesofpim447apanpiminhibitortargetingrefractorymyeloidleukemiawithkitdrivent821